Search by Drug Name or NDC

    NDC 00517-1045-05 Levocarnitine 200 mg/mL Details

    Levocarnitine 200 mg/mL

    Levocarnitine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Regent, Inc.. The primary component is LEVOCARNITINE.

    Product Information

    NDC 00517-1045
    Product ID 0517-1045_6da188f1-f972-4949-9764-da02eb63d113
    Associated GPIs
    GCN Sequence Number 046990
    GCN Sequence Number Description levocarnitine VIAL 200 MG/ML INTRAVEN
    HIC3 C7D
    HIC3 Description METABOLIC DEFICIENCY AGENTS
    GCN 85421
    HICL Sequence Number 000859
    HICL Sequence Number Description LEVOCARNITINE
    Brand/Generic Generic
    Proprietary Name Levocarnitine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levocarnitine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 200
    Active Ingredient Units mg/mL
    Substance Name LEVOCARNITINE
    Labeler Name American Regent, Inc.
    Pharmaceutical Class Carnitine Analog [EPC], Carnitine [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075861
    Listing Certified Through 2024-12-31

    Package

    NDC 00517-1045-05 (00517104505)

    NDC Package Code 0517-1045-05
    Billing NDC 00517104505
    Package 5 VIAL, SINGLE-DOSE in 1 TRAY (0517-1045-05) / 5 mL in 1 VIAL, SINGLE-DOSE (0517-1045-01)
    Marketing Start Date 2023-04-01
    NDC Exclude Flag N
    Pricing Information N/A